spacer
home > pmps > winter 2002 > the financial and operational benefits of e-learning in regulatory compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Financial and Operational Benefits of e-Learning in Regulatory Compliance

We believe that e-learning will increasingly be employed by pharmaceutical organisations to achieve and maintain compliance training as mandated by the regulatory authorities. e-Learning not only enhances compliance initiatives but also delivers the benefits of improved operational efficiency and higher profitability. Given the global nature of today's pharmaceutical operations, as well as an increased regulatory burden, e-learning has found a niche in the pharmaceutical manufacturing process, and ties in well with new FDA technology initiatives.

It has been well documented that e-learning cuts down the learning curve and delivers significant cost savings associated with traditional instructor led training (ILT). Furthermore, its interactive nature improves employee (student) material retention rates, and offers companies with customised solutions to their training needs. Since e-learning and computer-based training (CBT) integrates and complements traditional classroom-based training programmes, companies could achieve higher employee productivity by adopting a blended approach to learning.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Chakri Lokapriya, Managing Consultant - Compliance Solutions, and Tony Kypreos, Chief Commercial Officer, at Maersk Data UK
Chakri Lokapriya is Managing Consultant - Compliance Solutions at Maersk Data UK, a company which provides tailored audits and pilots in the areas of validation process, electronic records and signatures and computer validation. Prior to this, he was an Equity Analyst covering health care companies at JP Morgan and UBS Warburg. Chakri is a Director of Prinvex.

Tony Kypreos is Chief Commercial Officer at Maersk Data UK. Prior to this, he was European Vice-President of Strategic Services at Omnicom Group, and for nine years he held senior marketing and sales roles for Nestlй and Diageo.


spacer
Chakri Lokapriya
spacer
spacer
spacer
Tony Kypreos
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ISO 45001: Global occupational safety and health are important to Gerresheimer

Düsseldorf, June 30,2020: The Gerresheimer Group has declared DIN EN ISO 45001 to be the mandatory global standard for all its plants. It replaces thepreviously applicable standard OHSAS 18001in the field of occupational health and safety.
More info >>

White Papers

Conveying Medical Guidance in Clinical Trials – A Survey

Europital Medical Consultancy

With the incremental demand for proactive safety surveillance throughout the conduct of clinical trials, the role of Medical Management is at the fore in ensuring the safety and wellbeing of the participants. The complex responsibilities of a Medical Monitor (MM) starts from the design and development phase, through to study close out. Understanding the principle behind the protocol and the prospective medical solution the study would deliver forms the bloodline for the MM role. Often, the MM is the face of contact for both the site personnel and the study team members with regard to medical, safety and scientific issues within the project. When it comes to medical guidance, the communication channel used to deliver solutions contributes to a large extent in effectively managing decisive situations. Our previous study on acquiring medical guidance from an operations team perspective revealed that e-mails were the most used communication method (see the article, 'Talking Points', in ICT November 2014). In our efforts to further strengthen the mode of medical guidance delivery, we designed a survey to study the existing trend and constraints in this communication chain management, as outlined here.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement